Molecular Imaging Branch

MIB supports in vivo cancer molecular imaging by providing a definitive, minimal, or noninvasive assay of the molecular status of cancer cells and their environment in preclinical models and clinical settings. The realization of that goal requires: 

• In vivo molecular imaging agents that detect and report perturbations of genes, gene products, molecular pathways, PD, and physiological
  processes in cancer
• Imaging technologies capable of detecting rare events at the highest resolution in vivo
• Advanced image reconstruction and processing capabilities
• Highly multidisciplinary approaches

CIP supports these approaches primarily through its extramural grant program and by:

• Supporting state-of-the-science workshops and conversations across multi-disciplinary communities
• Collaborating with the Molecular Imaging Program in the NCI Center for Cancer Research and the Molecular Imaging Clinic in the NIH Clinical Center